Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
Autor: | Moon, Helen H., Kearney, Mairead, Mahmoudpour, Seyed Hamidreza, Ike, Chiemeka, Morris, Valerie A., Rava, Andrew, Kim, Sonia, Sun, Haiyan, Boyd, Marley, Gomez Rey, Gabriel |
---|---|
Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p605-605, 193p |
Databáze: | Supplemental Index |
Externí odkaz: |